Use UNICORN Signals App By EquityPandit
Latest News

German regulator rejects GMP approval to DRL’s Bachupally Unit2

The German regulator has not renewed good manufacturing practise (GMP) compliance certificate of Dr Reddy’s Laboratories formulations facility 2 in Bachupally in Hyderabad.

Dr Reddy’s Laboratories said in a BSE filing that the communication came after a recent inspection of the plant.

It added that Betapharm Arzneimittel GmbH, Germany, the company’s wholly owned arm received a communication “from the regulatory authority of Germany (Regiergun von Oberbayern) last night, that the GMP compliance certificate in respect of company’s formulations manufacturing Unit 2 plant in Bachupally, Hyderabad, is not renewed consequent to the recent inspection of the plant.”

Read EquityPandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile


Latest
IPO
Weekly
Outlook

Stock
Market
Prediction